Terms of Governance
These Terms of Governance outline the architectural invariants, human-in-the-loop oversight principles, reviewer accountabilities, and operational SLAs that govern Zen Health's clinical safety platform.
Last Updated: August 2026
Model Use Disclosure & PHI Scrubbing Rule
Model use is fully disclosed across all review workflows. Every model call is prompt-versioned and logged on every finding. PHI is scrubbed before any model receives a case. Models surface medical evidence; they never sign or render official regulatory decisions.
Reviewer Accountabilities & Append-Only Evidence Ledger
Assigned medical reviewers may accept, edit, or reject any validator finding. When a reviewer acts, the entry of a decision rationale is recorded. No deletion of records is permitted — corrections and updates are appended, ensuring history is preserved and cases remain fully reconstructable.
21 CFR Part 11 & GxP Validation Readiness
Zen Health is designed to support 21 CFR Part 11 signature-manifestation and audit-trail requirements. Formal customer validation (IQ/OQ protocols) under their own SOPs is supported for regulated production use.
Product Transparency & Validation Documentation
Safety database connectors (Oracle Argus, ArisGlobal, Veeva Safety) and clinical trial protocol pipelines follow validated deployment standards. All enterprise client engagements include comprehensive release documentation, formal validation deliverables (URS/FS/Traceability), and operational SLAs.
Clinical Decision Support (CDS) Disclaimer & Medical Responsibility
Zen Health functions strictly as clinical safety decision support software. The platform does not render autonomous medical diagnoses or patient treatment decisions. Final clinical judgments and regulatory submission filings remain the sole responsibility of credentialed physician reviewers of record, principal investigators, and trial sponsors.
Operational Availability & Real-Time Signal Dispatch SLAs
Continuous protocol monitoring operates on high-availability infrastructure with 99.9% uptime commitments. Real-time safety signal alerts (e.g., Grade 3+ CRS/ICANS or Dose-Limiting Toxicity events) are dispatched to the designated reviewer queue immediately upon data normalization.
Contact Information & Governance Inquiries
For questions regarding system governance rules, reviewer accountabilities, or operational SLAs, please contact our medical governance team.
Have questions about system SLAs or governance rules?
Contact our medical governance team for operational agreements and pilot terms.
